Coronavirus Disease 2019 (COVID-19) Update

Coronavirus Disease 2019 (COVID-19) Update

FDA is an active partner in the coronavirus disease (COVID-19) response, working closely with our government and public health partners across the U.S. Department of Health and Human Services, and with our international counterparts. Actions by the FDA in our ongoing response to the COVID-19 pandemic include:

Coronavirus (COVID-19) Updates:

• March 24, 2020 - Daily roundup (on a variety of FDA actions)
• March 24, 2020 - FDA takes action to increase U.S. supplies through instructions for PPE and device manufacturers
• March 24, 2020 - FDA Helps Facilitate Veterinary Telemedicine During Pandemic
• March 23, 2020 - Daily roundup (on a variety of FDA actions)
• March 22, 2020 - FDA provides update on patient access to certain REMS drugs during COVID-19 public health emergency
• March 22, 2020 - FDA Continues to Facilitate Access to Crucial Medical Products, Including Ventilators
• March 21, 2020 - FDA Issues first Emergency Use Authorization for Point of Care Diagnostic
• March 20, 2020 - FDA Alerts Consumers About Unauthorized Fraudulent COVID-19 Test Kits
• March 20, 2020 - FDA allows expanded use of devices to monitor patients’ vital signs remotely
• March 20, 2020 - FDA provides guidance on production of alcohol-based hand sanitizer to help boost supply, protect public health
• March 19, 2020 - FDA Continues to Facilitate Development of Treatments
• March 19, 2020 - Blood Donations
• March 18, 2020 - FDA Focuses on Safety of Regulated Products While Scaling Back Domestic Inspections
• March 18, 2020 - FDA Issues Guidance for Conducting Clinical Trials

Find additional coronavirus disease 2019 (COVID-19) updates on our website and in the Medical Countermeasures Initiative newsletter.